Although a high percentage of MTAP deletion was found in several clinicopathologic cancer studies (Bertino et al, 2011; Su et al, 2014; Kryukov et al, 2016; Woollard et al, 2016), MTAP gene deletion associated with the invasive and/or metastatic processes is the first time to be mentioned. This evidence concerns the gene MTAP and cancer.